EdwardAllenLevineMD

Breast, Melanoma, Surgical Oncology (Other than Breast), Trauma Surgery & Surgical Critical Care

Chief of surgical sciences, professor at Wake Forest University and director-at-large of Wake Forest Comprehensive Cancer Center.

Join to view full profile

Dr. Levine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levine's full profile

Already have an account?

Office
S Hawthorne Rd
Winston Salem, NC 27157
Phone+1 336-716-2255

Fax+1 336-716-6637

Summary

Uh Dr. Edward Levine is a surgical oncologist in Winston Salem. He is Professor of Surgery,and Chief, Surgical Oncology at Wake Forest Medical Center. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 30 years. His practice is limited to surgical oncology.

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Complex General Surgical Oncology, 1990 - 1992
Michael Reese Hospital and Medical CenterResidency, Surgery, 1985 - 1990
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1985

Certifications & Licensure

NC State Medical License 1998 - 2025
LA State Medical License 1992 - 1998
IL State Medical License 1985 - 1993
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2018
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Start of enrollment: 2004 Sep 30
Completed
Not Applicable
Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer Start of enrollment: 2004 Oct 15
Completed
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder Start of enrollment: 1999 Feb 01
Completed
Vaccine Therapy in Treating Patients With Breast Cancer Start of enrollment: 2007 Jan 01
Completed
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors Start of enrollment: 2004 May 01
Recruiting
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Start of enrollment: 2008 Sep 01
Active, not recruiting
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix Start of enrollment: 2009 May 01
Completed
Phase 2
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

701 citations
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intra...
Terence C. Chua, B. J. Moran, Paul H. Sugarbaker, Edward A. Levine, Olivier Glehen
Journal of Clinical Oncology. 2012-07-10
86 citations
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Shigeki Kusamura, Francesco Barretta, Yutaka Yonemura, Paul H. Sugarbaker, B. J. Moran
JAMA Surgery. 2021-03-01
461 citations
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Dominique Elias
Journal of Clinical Oncology. 2009-12-20

Journal Articles

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
Edward A Levine, Armando Sardi, JAMA Surgery
Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database
John Phay, Lawrence A Shirley, Lauren M Postlewait, Carmen C Solorzano, Colleen M Kiernan, Ioannis Hatzaras, Natalie Seiser, Tracy S Wang, Ryan C Fields, Konstantinos ..., Annals of Surgical Oncology
A Multi-Center Randomized Trial to Evaluate Hematologic Toxicities after HIPEC with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.
Levine EA, et. al., Journal of the American College of Surgeons 2018; 226: 434-445., 2018

Grant Support

NRG. Site #124 (U10CA 180790) Grant; Principal Investigator 2014 - present.NRG/NCI2014–Present
Genomics of Appendiceal CancerNational organization of Rare Diseases2012–Present
Comprehensive Cancer Center P30 CA012197-43 (Pasche PI) Roles: Director, Tissue Core Facility, Internal Advisory Board, Senior Advisor to the Director.NIH/NCI2017–2022
Tumor Tissue CoreNational Cancer Institute2007–2011
Clinical Trial: Study Of Tamoxifen And Raloxifene (STAR) For Prevention Of BreasNational Center For Research Resources2008–2010
Study Of Tamoxifen And Raloxifene (STAR) For Prevention Of Breast CancerNational Center For Research Resources2004–2007
PET In Multimodality Therapy For Esophageal CancerNational Cancer Institute2001–2002